These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33397191)

  • 1. Rational selection of building blocks for the assembly of bispecific antibodies.
    Gong D; Riley TP; Bzymek KP; Correia AR; Li D; Spahr C; Robinson JH; Case RB; Wang Z; Garces F
    MAbs; 2021; 13(1):1870058. PubMed ID: 33397191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics.
    Ching KH; Berg K; Reynolds K; Pedersen D; Macias A; Abdiche YN; Harriman WD; Leighton PA
    MAbs; 2021; 13(1):1862451. PubMed ID: 33491549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
    Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
    Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG-like bispecific antibody platforms with built-in purification-facilitating elements.
    Li Y
    Protein Expr Purif; 2021 Dec; 188():105955. PubMed ID: 34416361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies.
    Cooke HA; Arndt J; Quan C; Shapiro RI; Wen D; Foley S; Vecchi MM; Preyer M
    MAbs; 2018; 10(8):1248-1259. PubMed ID: 30215570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering bispecific antibodies with defined chain pairing.
    Krah S; Sellmann C; Rhiel L; Schröter C; Dickgiesser S; Beck J; Zielonka S; Toleikis L; Hock B; Kolmar H; Becker S
    N Biotechnol; 2017 Oct; 39(Pt B):167-173. PubMed ID: 28137467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Chain Pairing Variants of Bispecific IgG Expressed in a Single Host Cell by High-Resolution Native and Denaturing Mass Spectrometry.
    Schachner L; Han G; Dillon M; Zhou J; McCarty L; Ellerman D; Yin Y; Spiess C; Lill JR; Carter PJ; Sandoval W
    Anal Chem; 2016 Dec; 88(24):12122-12127. PubMed ID: 28193052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Antibody Bispecifics through Phage Display Selection.
    Luthra A; Langley DB; Schofield P; Jackson J; Abdelatti M; Rouet R; Nevoltris D; Mazigi O; Crossett B; Christie M; Christ D
    Biochemistry; 2019 Apr; 58(13):1701-1704. PubMed ID: 30900875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells.
    Joshi KK; Phung W; Han G; Yin Y; Kim I; Sandoval W; Carter PJ
    MAbs; 2019 Oct; 11(7):1254-1265. PubMed ID: 31286843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometry.
    Yin Y; Han G; Zhou J; Dillon M; McCarty L; Gavino L; Ellerman D; Spiess C; Sandoval W; Carter PJ
    MAbs; 2016; 8(8):1467-1476. PubMed ID: 27610742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implications for a single-step purification of bispecific antibodies.
    Lindhofer H; Mocikat R; Steipe B; Thierfelder S
    J Immunol; 1995 Jul; 155(1):219-25. PubMed ID: 7602098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel CH1:CL interfaces that enhance correct light chain pairing in heterodimeric bispecific antibodies.
    Bönisch M; Sellmann C; Maresch D; Halbig C; Becker S; Toleikis L; Hock B; Rüker F
    Protein Eng Des Sel; 2017 Sep; 30(9):685-696. PubMed ID: 28981885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.
    Froning KJ; Leaver-Fay A; Wu X; Phan S; Gao L; Huang F; Pustilnik A; Bacica M; Houlihan K; Chai Q; Fitchett JR; Hendle J; Kuhlman B; Demarest SJ
    Protein Sci; 2017 Oct; 26(10):2021-2038. PubMed ID: 28726352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG.
    Fischer N; Elson G; Magistrelli G; Dheilly E; Fouque N; Laurendon A; Gueneau F; Ravn U; Depoisier JF; Moine V; Raimondi S; Malinge P; Di Grazia L; Rousseau F; Poitevin Y; Calloud S; Cayatte PA; Alcoz M; Pontini G; Fagète S; Broyer L; Corbier M; Schrag D; Didelot G; Bosson N; Costes N; Cons L; Buatois V; Johnson Z; Ferlin W; Masternak K; Kosco-Vilbois M
    Nat Commun; 2015 Feb; 6():6113. PubMed ID: 25672245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LUZ-Y, a novel platform for the mammalian cell production of full-length IgG-bispecific antibodies.
    Wranik BJ; Christensen EL; Schaefer G; Jackman JK; Vendel AC; Eaton D
    J Biol Chem; 2012 Dec; 287(52):43331-9. PubMed ID: 23118228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry.
    Schaefer W; Völger HR; Lorenz S; Imhof-Jung S; Regula JT; Klein C; Mølhøj M
    MAbs; 2016; 8(1):49-55. PubMed ID: 26496506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection.
    Klewinghaus D; Pekar L; Arras P; Krah S; Valldorf B; Kolmar H; Zielonka S
    Front Immunol; 2021; 12():801368. PubMed ID: 35087526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation.
    Debaene F; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2013 Oct; 85(20):9785-92. PubMed ID: 24007193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies.
    Wu X; Sereno AJ; Huang F; Zhang K; Batt M; Fitchett JR; He D; Rick HL; Conner EM; Demarest SJ
    MAbs; 2015; 7(2):364-76. PubMed ID: 25611120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Bispecific Antibody Production in Cell Cultures by Unique Mixed Mode Size Exclusion Chromatography.
    Jiang H; Xu W; Liu R; Gupta B; Kilgore B; Du Z; Yang X
    Anal Chem; 2020 Jul; 92(13):9312-9321. PubMed ID: 32497423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.